Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Alpha-GPC (alpha-glycerylphosphorylcholine)

L-Alpha Glycerylphosphorylcholine (Alpha-GPC) · also known as Alpha-glycerylphosphorylcholine, Alpha-GPC

Alpha-GPC is a precursor of choline and can supply choline for acetylcholine synthesis. A rise in free choline in human plasma is supported by evidence, but effects at the synapse remain unclear, and the evidence for central effects comes mainly from animal studies.

Typical dose: Common doses are 300–1200 mg/day, taken in the morning or 30–45 minutes before intense mental work or training. In its 2026 assessment of a notified product, the European Food Safety Authority (EFSA) considered intakes of up to 203.7 mg/day, so that assessment does not directly show that long-term use at 300–1200 mg/day is safe.
Absorption and forms: Alpha-GPC absorbs moisture and hydrolyzes easily, so pure powder needs strict protection from moisture. It cannot be established as the most efficient choline source for crossing the human blood-brain barrier, and its advantage over other choline sources such as choline bitartrate is not well supported by evidence. Gastrointestinal discomfort or a trimethylamine odor cannot be ruled out either.

Clinical uses and human evidence

Age-related cognitive decline

BeneficialGrade B · Moderate evidence
Studies (2)
  1. De Jesus Moreno Moreno 2003 · Clin Ther · RCT · n=261 — Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial
  2. Jeon 2024 · BMC Geriatr · RCT · n=100 — Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial

Attention and focus

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Kerksick 2024 · Nutrients · randomized crossover trial · n=20 — Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men

Muscle strength and mass

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Bellar 2015 · J Int Soc Sports Nutr · randomized crossover trial · n=13 — The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength

Mechanisms of action

Cholinergic neurotransmission (ACh precursor supply and AChE inhibition)

★★★★☆Mechanism evidence: grade B

Alpha-GPC breaks down to release choline, which serves as a raw material for acetylcholine synthesis. A rise in free choline in human plasma supports its role as a precursor supply, but this alone does not show that acetylcholine in the synaptic cleft increases. The evidence for central cholinergic effects comes mainly from animal studies.

References (2)
  1. EFSA 2026 · Human pharmacokinetic evaluation: plasma free choline rose after oral alpha-GPC
  2. 1992 · Rat study: alpha-GPC enhanced cholinergic transmission in the hippocampus

Autonomic balance and vagal tone

★★☆☆☆Mechanism evidence: grade BSecondary target

In a randomized crossover trial of 12 overweight or obese women, a single 1000 mg dose raised the high-frequency component of resting heart rate variability and led to faster recovery after sprint exercise. The sample was small, and only a single dose was tested.

References (1)
  1. Barzanjeh 2022 · Nutrients · randomized crossover trial · n=12 — The Effects of Alpha-Glycerylphosphorylcholine on Heart Rate Variability and Hemodynamic Variables Following Sprint Interval Exercise in Overweight and Obese Women

Neurotrophic factor synthesis and TrkB/A receptor activation

★★☆☆☆Mechanism evidence: grade CSecondary target

In high-dose animal experiments, oral alpha-GPC was associated with increased hippocampal BDNF expression. The causal pathway between cholinergic stimulation and BDNF upregulation has not been confirmed, and its role in humans is also unclear.

References (1)
  1. 2022 · Rat stress model study: high-dose oral alpha-GPC was associated with increased hippocampal BDNF expression

Safety and drug interactions

People prone to insomnia should avoid taking it in the evening. With long-term very high doses, keep an eye on plasma TMAO levels. One observational cohort study found that alpha-GPC prescriptions were associated with stroke risk, but the finding is subject to confounding, so it cannot be taken as proof of cause and effect. People with a history of cardiovascular or cerebrovascular disease should consult a doctor first.
Open in the interactive app ›